Why work with us?
RS Research is a clinical-stage biotechnology company using its Sagitta® platform to enable targeted drug delivery and smart chemotherapy that aims for more benefit with fewer side effects.
Since its founding, RS Research has demonstrated strong execution and investor confidence, raising a 2 million EUR seed investment in 2017 followed by a 12 million USD Series-A investment round, ranking among the top 10 largest start-up investments in Türkiye in 2021. We are proud to have been the first biotech company to be included in this “top investments” list. Our scientific excellence and strategic vision have been internationally recognized through many awards, reflecting the strength of our intellectual property, robust technology and visionary business strategy.
With operations based in Istanbul and Lausanne, RS Research is entering a pivotal growth phase and is well positioned to take the next steps toward becoming a global player in drug development. We are on the threshold of significant milestones across clinical development, platform expansion, and international co-development partnerships.
Our roadmap offers unique opportunities for individuals who are driven by innovation, impact, and continuous achievement. From advancing a diverse clinical pipeline to shaping global collaborations, RS Research provides an environment where ambitious ideas are encouraged and excellence is celebrated.
We are always eager to welcome curious, creative, and forward-thinking professionals who are ready to challenge conventions and contribute to meaningful change in healthcare.
Explore the opportunities to be a part of a brilliant multidisciplinary team.
